The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,417.00
Bid: 1,487.00
Ask: 1,347.00
Change: -21.00 (-1.46%)
Spread: -140.00 (-9.415%)
Open: 1,432.00
High: 1,448.00
Low: 1,412.00
Prev. Close: 1,438.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 Tanks As Pound Surges And UK Banks Slide

Thu, 18th Feb 2021 17:00

(Alliance News) - UK banks and a stronger pound weighed on the FTSE 100 on Thursday, with the market mood downbeat as disappointing US jobless claims served as a reminder that the short-term global economic outlook remains challenging.

The internationally-exposed FTSE 100 index closed down 93.75 points, or 1.4%, at 6,617.15. The FTSE 250 ended down 215.62 points, or 1.0%, at 20,933.87, and the AIM All-Share closed down 17.24 points, or 0.4%, at 1,205.88.

The Cboe UK 100 ended down 1.6% at 657.09, the Cboe UK 250 closed down 1.0% at 18,513.76, and the Cboe Small Companies ended down 0.4% at 12,768.78.

In European equities on Thursday, the CAC 40 in Paris ended down 0.7%, while the DAX 30 in Frankfurt ended down 0.2%.

"Given their recent levels, it's not really a surprise that certain markets were in danger of moving sharply lower at the slightest provocation," said Connor Campbell at Spreadex, noting a deterioration in US weekly jobless claims.

The number of US workers filing for first-time unemployment benefits unexpectedly rose last week amid a lack of fiscal support, the latest figures from the Department of Labor showed on Thursday.

For the week ending February 13, initial claims were 861,000, an increase of 13,000 from the previous week's revised figure of 848,000. The latest print was higher than the market forecast, cited by FXStreet, of 765,000 claims.

US President Joe Biden's USD1.9 trillion economic rescue package remains in Congress, awaiting passage.

This ensured Wall Street started Thursday's session on the back foot. Stocks in New York were lower at the London equities close, with the DJIA down 0.8%, the S&P 500 index down 0.8%, and the Nasdaq Composite down 1.2%.

Spreadex's Campbell said: "A combination of doubts introduced by the Dow Jones, and the ascension of sterling, left the FTSE as far and away Thursday's worst performer."

Sterling was trading around its best levels since April 2018. The pound was quoted at USD1.3955 at the London equities close Thursday, compared to USD1.3845 at the close on Wednesday.

Fawad Razaqzada, market analyst at ThinkMarkets, said the pound is "shining brightly".

"Like the US, bond yields in the UK have been rising, especially after a no-deal Brexit was avoided at the back end of last year. The UK is currently well ahead of many countries in the race to vaccinate its population. Together, these developments have boosted expectations that the UK economy could potentially recover quicker and stronger once lockdowns end," said Razaqzada.

UK Prime Minister Boris Johnson is awaiting new data on the effects of vaccines on coronavirus after stressing he will take a "cautious and prudent approach" to easing England's national lockdown.

The prime minister is understood to be expecting updated evidence of jabs' effect on hospital admissions and deaths to be with him by the end of Friday, ahead of setting out his "road map" next week. But it was unclear whether the early data would include vaccines' effect on transmission, with the results of two key Public Health England studies possibly not available until next month.

Johnson stressed on Wednesday that any easing of restrictions needs to be in stages and in an "irreversible" way as he was urged to focus on the evidence rather than deadlines when lifting restrictions.

The euro stood at USD1.2076 at the European equities close Thursday, up against USD1.2036 at the same time on Wednesday.

Against the yen, the dollar fell to JPY105.72 compared to JPY105.82 late Wednesday.

Brent oil was quoted at USD64.49 a barrel at the London equities close Thursday, rising from USD63.53 late Wednesday. Gold firmed at USD1,776.28 an ounce at the London equities close Thursday against USD1,774.53 at the close on Wednesday.

In London, banks ended Thursday's session in the red, dragged down as Barclays kicked off the full-year reporting season for UK banks. Barclays shares ended down 4.4%.

"On the face of it you might have expected a round of applause for Barclays fourth quarter results...Instead the company got the cold shoulder from the market as attention was drawn by large provisions on Covid-related bad debt and a warning of a continuing impact through the course of 2021," said AJ Bell investment director Russ Mould.

For 2020, Barclays posted net income of GBP21.77 billion, up 1% from GBP21.63 billion in 2019, as net interest income fell 14% to GBP8.12 billion from GBP9.41 billion. Pretax profit sank 30% to GBP3.07 billion from GBP4.36 billion. However, the figure beat company-compiled consensus which forecast a pretax profit of GBP2.81 billion.

Barclays booked GBP4.84 billion in credit impairments in 2020, more than doubled from GBP1.91 billion in 2019.

The lender declared a dividend of 1.0 pence for 2020, down from 3.0p paid in 2019. In addition, Barclays said it intends to initiate a share buyback of up to GBP700 million, which is expected to commence in the first quarter of 2021.

AJ Bell's Mould added: "There may also have been some disappointment at the pretty nominal nature of the dividend – though anyone who thought payouts were going straight back to pre-pandemic levels in a hurry wasn't paying attention."

The banking sector ended lower, with NatWest - due to report its own 2020 results on Friday - slipping 3.9%, Lloyds Group ending down 3.7% and HSBC shedding 3.0%.

Also weighing on the FTSE 100 was Smith & Nephew, sliding 5.9% as it posted a fall in profit for 2020.

For the year, Smith & Nephew posted trading profit of USD683 million, almost halved from the USD1.17 billion recorded for 2019. This was as revenue fell 11% to USD4.56 billion from USD5.14 billion. Pretax profit was GBP246 million, down 67% from GBP743 million.

S&N declared a full-year dividend of 37.5 US cents per share, unchanged from 2019, reflecting "confidence in the business and strength of the balance sheet".

Looking ahead, the company said the outlook reflects the likely continuation of Covid-19 effects during the first half of 2021 and the uncertainty regarding the timing and pace of recovery.

Moneysupermarket.com and Indivior were top and tailing the FTSE 250.

Shares in Moneysupermarket.com rose 7.1% as the Chester, England-headquartered price comparison website reported a sharp drop in annual profit, but was able to maintain its dividend.

For 2020, Moneysupermarket recorded pretax profit of GBP87.8 million, down 24% from GBP116.0 million in 2019. Active users dipped to 11.5 million from 13.1 million, while revenue per active user fell to GBP16.19 from GBP16.40.

Moneysupermarket maintained its annual dividend at 11.71p.

Indivior, meanwhile, slumped 6.5% as it said the possibility remains that 2021 will be significantly hurt by the Covid-19 pandemic.

For 2020, Invidior swung to a pretax loss of USD173 million from a USD180 million profit recorded on 2019. This was as net revenue fell 18% year-on-year to USD647 million from USD785 million amid competition from cheaper generic drugs to treat opioid dependence as well as disruption from the pandemic.

Looking ahead, Slough-based Indivior said: "Base case net revenue guidance assumes the operating backdrop will improve in first half 2021, as Covid-19 pandemic restrictions impacting in-person healthcare practitioner access subside and healthcare systems approach normality. In a downside scenario in which the operating backdrop continues to be adversely impacted by pandemic restrictions through second half 2021, Indivior believes total net revenue for 2021 could be adversely impacted by up to USD60 million. On this basis, total net revenue could be around USD565 million."

The UK corporate calendar on Friday has full-year results from lender NatWest and property investor Segro.

In the economic calendar for Friday, UK retail sales are at 0700 GMT with German producer prices due at the same time. There are then PMIs due for Germany, the eurozone and the UK at 0830 GMT, 0900 GMT and 0930 GMT respectively. The US PMI is out at 1445 GMT.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more
20 Apr 2023 15:41

UK earnings, trading statements calendar - next 7 days

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Mar 2023 17:47

IN BRIEF: Indivior completes acquisition of Opiant Pharmaceuticals

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.